Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-25

Clinical Trial Update: SASS 2 : Self Assembled Skin Substitute for the Autologous Treatment of Severe Burn Wounds in Acute Stage of Burn Trauma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial is evaluating Self Assembled Skin Substitute (SASS) for autologous treatment of severe burn wounds, currently in Phase 1/2 and recruiting. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Self Assembled Skin Substitute (SASS)

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Burns | Phase 1, Phase 2 | Status: RECRUITING